Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Tenet Healthcare ( THC) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day down 0.2%. By the end of trading, Tenet Healthcare rose $0.78 (1.8%) to $43.15 on average volume. Throughout the day, 1,634,300 shares of Tenet Healthcare exchanged hands as compared to its average daily volume of 1,904,900 shares. The stock ranged in a price between $42.01-$43.22 after having opened the day at $42.07 as compared to the previous trading day's close of $42.37. Other companies within the Health Care sector that increased today were: OncoMed Pharmaceuticals ( OMED), up 97.9%, EnteroMedics ( ETRM), up 63.5%, Conatus Pharmaceuticals ( CNAT), up 18.1% and Unilife Corporation ( UNIS), up 16.6%.

Tenet Healthcare Corporation, an investor-owned health care services company, owns and operates acute care hospitals, ambulatory surgery centers, diagnostic imaging centers, urgent care centers, and related health care facilities in the United States. Tenet Healthcare has a market cap of $4.3 billion and is part of the health services industry. Shares are up 32.9% year to date as of the close of trading on Monday. Currently there are 8 analysts that rate Tenet Healthcare a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Tenet Healthcare as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share and revenue growth. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, generally higher debt management risk and disappointing return on equity.

On the negative front, Mast Therapeutics ( MSTX), down 39.4%, Echo Therapeutics ( ECTE), down 17.2%, PDL BioPharma ( PDLI), down 11.2% and Vision-Sciences Inc (DE ( VSCI), down 10.8% , were all laggards within the health care sector with Gilead ( GILD) being today's health care sector laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.